Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma
Clinical trial NCT00107718 · COMPLETED
Trial details
- NCT number
- NCT00107718
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-15
- Primary completion
- 2006-05-19
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.